BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 178 filers reported holding BLUEBIRD BIO INC in Q1 2022. The put-call ratio across all filers is 1.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $258,746 | +9.3% | 37,391 | 0.0% | 0.00% | – |
| Q3 2022 | $236,685 | +52.9% | 37,391 | 0.0% | 0.00% | – |
| Q2 2022 | $154,799 | -14.6% | 37,391 | -0.0% | 0.00% | – |
| Q1 2022 | $181,351 | -95.6% | 37,392 | -91.0% | 0.00% | -100.0% |
| Q4 2021 | $4,128,000 | -59.0% | 413,232 | -21.5% | 0.00% | -50.0% |
| Q3 2021 | $10,062,000 | -37.1% | 526,554 | +5.2% | 0.00% | -33.3% |
| Q2 2021 | $16,003,000 | +30.9% | 500,403 | +23.4% | 0.00% | 0.0% |
| Q1 2021 | $12,229,000 | -61.8% | 405,614 | -45.2% | 0.00% | -57.1% |
| Q4 2020 | $32,027,000 | -15.8% | 740,162 | +5.0% | 0.01% | -30.0% |
| Q3 2020 | $38,015,000 | +5.0% | 704,643 | +18.8% | 0.01% | 0.0% |
| Q2 2020 | $36,219,000 | +62.3% | 593,371 | +22.2% | 0.01% | +25.0% |
| Q1 2020 | $22,313,000 | -46.4% | 485,484 | +2.3% | 0.01% | -33.3% |
| Q4 2019 | $41,636,000 | -4.4% | 474,488 | 0.0% | 0.01% | -7.7% |
| Q3 2019 | $43,568,000 | -27.8% | 474,488 | 0.0% | 0.01% | -31.6% |
| Q2 2019 | $60,355,000 | -15.9% | 474,488 | +4.0% | 0.02% | -17.4% |
| Q1 2019 | $71,792,000 | +63.8% | 456,316 | +3.3% | 0.02% | +43.8% |
| Q4 2018 | $43,816,000 | -28.3% | 441,688 | +5.5% | 0.02% | -20.0% |
| Q3 2018 | $61,140,000 | -5.9% | 418,766 | +1.2% | 0.02% | -9.1% |
| Q2 2018 | $64,941,000 | -15.7% | 413,766 | -8.3% | 0.02% | -21.4% |
| Q1 2018 | $77,035,000 | +8.6% | 451,157 | +13.3% | 0.03% | +12.0% |
| Q4 2017 | $70,929,000 | +34.7% | 398,254 | +3.9% | 0.02% | +25.0% |
| Q3 2017 | $52,640,000 | +30.7% | 383,254 | 0.0% | 0.02% | +25.0% |
| Q2 2017 | $40,261,000 | +19.1% | 383,254 | +3.1% | 0.02% | +14.3% |
| Q1 2017 | $33,796,000 | +47.3% | 371,793 | 0.0% | 0.01% | +40.0% |
| Q4 2016 | $22,940,000 | -16.2% | 371,793 | -12.0% | 0.01% | -23.1% |
| Q3 2016 | $27,359,000 | +162.7% | 422,618 | +75.6% | 0.01% | +160.0% |
| Q2 2016 | $10,416,000 | +1.6% | 240,604 | -0.3% | 0.01% | 0.0% |
| Q1 2016 | $10,252,000 | -33.8% | 241,230 | 0.0% | 0.01% | -37.5% |
| Q4 2015 | $15,492,000 | -20.9% | 241,230 | +5.4% | 0.01% | -20.0% |
| Q3 2015 | $19,582,000 | -51.6% | 228,897 | -4.7% | 0.01% | -50.0% |
| Q2 2015 | $40,419,000 | +140.5% | 240,063 | +72.5% | 0.02% | +150.0% |
| Q1 2015 | $16,803,000 | – | 139,129 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 6,335,528 | $40,104,000 | 4.92% |
| qPULA Trading Management LP | 14,344 | $91,000 | 0.80% |
| Frazier Life Sciences Management, L.P. | 1,440,757 | $9,120,000 | 0.70% |
| Ikarian Capital, LLC | 462,628 | $2,928,000 | 0.58% |
| Birchview Capital, LP | 98,000 | $620,000 | 0.44% |
| HealthCor Management, L.P. | 455,000 | $2,880,000 | 0.36% |
| Financial Advocates Investment Management | 45,071 | $3,538,000 | 0.29% |
| PDT Partners, LLC | 262,767 | $1,663,000 | 0.25% |
| Monaco Asset Management SAM | 80,000 | $506,000 | 0.19% |
| Summit X, LLC | 103,424 | $651,000 | 0.19% |